Cargando…
Gene signature driving invasive mucinous adenocarcinoma of the lung
Though invasive mucinous adenocarcinoma of the lung (IMA) is pathologically distinctive, the molecular mechanism driving IMA is not well understood, which hampers efforts to identify therapeutic targets. Here, by analyzing gene expression profiles of human and mouse IMA, we identified a Mucinous Lun...
Autores principales: | Guo, Minzhe, Tomoshige, Koichi, Meister, Michael, Muley, Thomas, Fukazawa, Takuya, Tsuchiya, Tomoshi, Karns, Rebekah, Warth, Arne, Fink‐Baldauf, Iris M, Nagayasu, Takeshi, Naomoto, Yoshio, Xu, Yan, Mall, Marcus A, Maeda, Yutaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376761/ https://www.ncbi.nlm.nih.gov/pubmed/28255028 http://dx.doi.org/10.15252/emmm.201606711 |
Ejemplares similares
-
CRISPRi-mediated functional analysis of NKX2-1-binding sites in the lung
por: Stuart, William D., et al.
Publicado: (2021) -
Clinical application of a lung cancer organoid (tumoroid) culture system
por: Yokota, Etsuko, et al.
Publicado: (2021) -
A favourable prognostic marker for EGFR mutant non-small cell lung cancer: immunohistochemical analysis of MUC5B
por: Wakata, Kouki, et al.
Publicado: (2015) -
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
por: Fukazawa, Takuya, et al.
Publicado: (2016) -
CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1
por: Fink-Baldauf, Iris M., et al.
Publicado: (2022)